Bullish
Zenas BioPharma reports positive phase 3 trial results for obexelimab By Investing.com
Zenas BioPharma announced positive results from its Phase 3 INDIGO trial for obexelimab in Immunoglobulin G4-Related Disease (IgG4-RD), meeting its pr...